Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oxygen saturation decreased, Palpitations, Pyrexia, SARS-CoV-2 test
Clinical narrative: Feeling hot; Palpitations; Shortness of Breath; Patient had a persistent dry cough; Patient had some chest tightnes; Oxygen Saturation 94%-97%; Fatigue; Sore leftarm; 99.1 Temperature; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Sep-2021. The most recent information was received on 11-Sep-2021 and was forwarded to Moderna on 11-Sep-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Patient had a persistent dry cough), CHEST DISCOMFORT (Patient had some chest tightnes), FATIGUE (Fatigue), MYALGIA (Sore leftarm) and FEELING HOT (Feeling hot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939906, 029L20N and 02UM20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to pegylated interferon used to treat Hep C in 1999, developed pulmonary sarcoidosis.), Hypertension since 2016, Hypothyroidism since 1999, Sleep apnea since 2017, Dyspnea exertional (Under investigation, started 6 months prior) since 2021 and Palpitations (No cause identified) since 2018. Concomitant products included ROSUVASTATIN for Cholesterol, ETHINYLESTRADIOL, NORETHISTERONE ACETATE (FYAVOLV) for Hormone replacement therapy, LOSARTAN for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, ZOLPIDEM TARTRATE (AMBIEN) for Sleep disorder.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Aug-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Sore leftarm) and PYREXIA (99.1 Temperature). On 01-Sep-2021, the patient experienced COUGH (Patient had a persistent dry cough), CHEST DISCOMFORT (Patient had some chest tightnes) and OXYGEN SATURATION DECREASED (Oxygen Saturation 94%-97%). On 02-Sep-2021, the patient experienced FEELING HOT (Feeling hot), PALPITATIONS (Palpitations) and DYSPNOEA (Shortness of Breath). On 08-Sep-2021, CHEST DISCOMFORT (Patient had some chest tightnes) had resolved. At the time of the report, COUGH (Patient had a persistent dry cough) and FEELING HOT (Feeling hot) had not resolved and FATIGUE (Fatigue), MYALGIA (Sore leftarm), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of Breath), PYREXIA (99.1 Temperature) and OXYGEN SATURATION DECREASED (Oxygen Saturation 94%-97%) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Sep-2021, SARS-CoV-2 test: negative (Negative) Negative.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       It was reported that from 03-Sep-2021 to 10-Sep-2021 dry cough slowly lessened, continued episodes of feeling hot but temperature was normal, intermittent fatigue.  On 11-Sep-2021 there was occasional dry cough. No further chest tightness. Continued intermittent feeling hot and periods of fatigue.   No Treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Sep-2021: Significant live Follow-up Append. Event split into two events. Lab data updated. First and second dose start dates added. Patient initials changed. Causality updated. On 11-Sep-2021: Follow-up received contains additional event outcomes, Causality assessment, patient initials, relevant history, concomitant medications, batch number of third dose updated.